Biomarker Detection
Tools for HER2, PD-L1, MSI/MMR, SOX2, TP63, CCND1, VEGFA, EGFR and GATA markers.
Explore research-use products for esophageal cancer biology, esophageal squamous cell carcinoma, esophageal adenocarcinoma, Barrett’s esophagus, GERD-associated metaplasia, squamous dysplasia, HER2 / ERBB2, PD-L1, MSI / MMR, SOX2, TP63, CCND1, VEGFA, GATA4, GATA6, EGFR, EMT, angiogenesis, invasion, metastasis, immune microenvironment studies, cell culture workflows and biomarker assay development.
Build esophageal tumor research workflows using antibodies, ELISA kits, recombinant proteins, molecular biology tools, cell culture reagents and functional assay systems.
Primary antibodies for HER2, PD-L1, SOX2, TP63, CCND1, VEGFA, EGFR, p53, Ki-67, cytokeratins, E-cadherin, EMT markers, MMPs and tumor microenvironment studies.
View antibodiesKits and assays for cytokines, angiogenesis markers, immune checkpoints, inflammatory mediators, VEGF, MMPs and esophageal tumor biology workflows.
View ELISA kitsRecombinant proteins, assay standards, positive controls, calibrators and validation tools for esophageal cancer biomarker assay development.
View proteinsMolecular tools for HER2 / ERBB2, MSI/MMR, PD-L1/CD274, SOX2, TP63, CCND1, VEGFA, GATA4/GATA6, EGFR, EMT and esophageal cancer subtype profiling.
View molecular toolsMedia, matrices, supplements, transfection reagents and model-system tools for ESCC, EAC, Barrett’s-associated models, spheroids and resistance workflows.
View culture toolsATP, cytotoxicity, apoptosis, proliferation, migration, invasion, DNA damage, oxidative stress, angiogenesis and immune-response assay systems.
View assay toolsEsophageal cancer research includes biomarkers linked to squamous lineage, adenocarcinoma signaling, immune evasion, angiogenesis, cell-cycle regulation, DNA repair and epithelial remodeling.
SOX2 is studied in esophageal squamous cell carcinoma differentiation, amplification patterns and squamous tumor identity.
TP63 supports research into basal/squamous epithelial programs, proliferation and ESCC lineage biology.
HER2 / ERBB2 is studied in esophageal adenocarcinoma and gastroesophageal junction tumor signaling, amplification and biomarker workflows.
PD-L1 is studied in esophageal tumor immune escape, checkpoint biology and tumor microenvironment research.
Choose a workflow and get product groups matched to esophageal tumor research needs.
Recommended product groups: primary antibodies, secondary antibodies, FFPE-compatible markers, antigen retrieval reagents, HER2, PD-L1, SOX2, TP63, CCND1, VEGFA, EGFR, Ki-67, p53, E-cadherin, cytokeratins and tissue controls.
Browse tissue research productsUse esophageal tumor research products across Barrett’s biology, squamous dysplasia, adenocarcinoma profiling, immune studies, angiogenesis and drug-response models.
Study metaplasia, epithelial stress, inflammatory signaling, dysplasia and EAC progression.
Analyze SOX2, TP63, CCND1, TP53, cytokeratins, proliferation and squamous differentiation.
Profile HER2/ERBB2, VEGFA, GATA4/GATA6, EGFR, glandular biology and GE-junction overlap.
Measure PD-L1, cytokines, T-cell markers, macrophage markers and stromal remodeling.
Study EMT markers, MMPs, migration, invasion, extracellular matrix remodeling and lymphatic spread.
Measure viability, apoptosis, DNA damage, cytotoxicity, radiosensitivity and therapy-response pathways.
Product selection should match the biological target, esophageal cancer subtype, sample type, assay format and validation requirements.
Examples: SOX2, TP63, CCND1, HER2, PD-L1, MSI/MMR, VEGFA, Barrett’s metaplasia, EMT or invasion.
Review whether the product supports ESCC, EAC, Barrett’s-associated dysplasia, GE-junction biology or immune/TME research.
Confirm suitability for IHC, WB, IF, ELISA, qPCR, flow cytometry, cell culture or functional assays.
Include positive controls, negative controls, calibrators, reference lysates, recombinant standards and reproducibility checks.
Explore research-use tools for esophageal tumor biology, ESCC, EAC, Barrett’s esophagus, HER2, PD-L1, MSI/MMR, SOX2, TP63, CCND1, VEGFA, EGFR, immune microenvironment studies, invasion and experimental drug-response workflows.
Clear answers to common product-selection and esophageal tumor workflow questions.
Esophageal cancer research products are laboratory-use reagents and assay tools used to study esophageal tumor biology, ESCC, EAC, Barrett’s-associated pathways, biomarkers, cell models, immune escape, invasion and drug response.
Frequently studied markers include HER2 / ERBB2, PD-L1, MSI/MMR, SOX2, TP63, CCND1, VEGFA, EGFR, TP53, Ki-67, E-cadherin, cytokeratins, MMPs and EMT markers.
Tissue-based studies commonly use primary antibodies, secondary antibodies, IHC reagents, FFPE-compatible controls, SOX2, TP63, HER2, PD-L1, VEGFA, Ki-67, p53 and cytokeratin markers.
No. Products described on this page are presented for research use only unless an individual product page clearly states otherwise.
Authoritative sources supporting esophageal cancer biology, biomarkers and research context.